Earnings (Loss) Per Share (Tables)

12 Months Ended

Dec. 31, 2024

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of basic and diluted earnings per share.


(In millions, except share and per share data)	Year Ended December 31,
		2024		2023		2022
Numerator:
Numerator for EPS - continuing operations
Net (loss) income from continuing operations		$	(598.1)	$	19.6	$	265.4

Less: Income from continuing operations attributed to non-controlling interests		39.5		26.9		33.4


Numerator for basic and diluted EPS from continuing operations attributable to Delek		$	(637.6)	$	(7.3)	$	232.0

Numerator for EPS - discontinued operations
Income from discontinued operations, including gain on sale of discontinued operations		$	105.9	$	35.2	$	32.6
Less: Income tax expense		28.7		8.1		7.5


Income from discontinued operations, net of tax		$	77.2	$	27.1	$	25.1

Denominator:
Weighted average common shares outstanding (denominator for basic EPS)		63,882,219		65,406,089		70,789,458


Dilutive effect of stock-based awards		—		—		726,903
Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS)		63,882,219		65,406,089		71,516,361

EPS:
Basic (loss) income per share:
(Loss) income from continuing operations		$	(9.98)	$	(0.11)	$	3.28
Income from discontinued operations		1.21		0.41		0.35
Total basic (loss) income per share		$	(8.77)	$	0.30	$	3.63
Diluted (loss) income per share:
(Loss) income from continuing operations		$	(9.98)	$	(0.11)	$	3.24
Income from discontinued operations		1.21		0.41		0.35
Total diluted (loss) income per share		$	(8.77)	$	0.30	$	3.59

The following equity instruments were excluded from the diluted weighted average common shares outstanding because their effect would be anti-dilutive:
Antidilutive stock-based compensation (because average share price is less than exercise price)		2,116,047		1,718,880		2,299,660
Antidilutive due to loss		467,499		569,212		—
Total antidilutive stock-based compensation		2,583,546		2,288,092		2,299,660